india semaglutide pharma companies develop versions of Wegovy to get in on weight-loss windfall Semaglutide LoE in India: A

Shanmugasundaram, K., et al

Cigna's list is unusually generous: "hypertension, type 2 diabetes, dyslipidemia, obstructive sleep apnea, cardiovascular disease, knee osteoarthritis, asthma, chronic obstructive pulmonary disease, metabolic dysfunction-associated steatotic liver disease/non-alcoholic fatty liver disease, polycystic ovarian syndrome, or coronary artery disease." The medication is used "concomitantly with behavioral modification and a reduced-calorie diet." Two details work in your favor

[DOI] [PMC free article] [PubMed] [Google Scholar] Donnelly D

The benefits are genuine, but they flow through the vasculature, the nervous system, and secondary mediators more than through the organs working cells, a distinction that matters when designing drugs meant to target these tissues

Glycine, an important one-carbon source, is the third amino acid added to -glutamylcysteine, the condensation product of glutamate and cysteine, to form glutathione (Figure 1)